Humana Inc: Form 10-Q for the period ended Sep 30, 2018
Filed with the SEC on Nov 7, 2018 and accepted by EDGAR at Nov 7, 2018, 16:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-07-01 to 2018-09-30 | $14.21bn | us-gaap:Revenues |
| Revenue | 9 months2018-01-01 to 2018-09-30 | $42.74bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2018-07-01 to 2018-09-30 | $1.90bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2018-01-01 to 2018-09-30 | $5.41bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-07-01 to 2018-09-30 | $961.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2018-01-01 to 2018-09-30 | $2.58bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-07-01 to 2018-09-30 | $53.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2018-01-01 to 2018-09-30 | $159.0m | us-gaap:InterestExpense |
| Income tax | 3 months2018-07-01 to 2018-09-30 | $266.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2018-01-01 to 2018-09-30 | $308.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-07-01 to 2018-09-30 | $644.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2018-01-01 to 2018-09-30 | $1.33bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-07-01 to 2018-09-30 | $4.65 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2018-01-01 to 2018-09-30 | $9.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-07-01 to 2018-09-30 | $4.68 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2018-01-01 to 2018-09-30 | $9.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-07-01 to 2018-09-30 | 138,678,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2018-01-01 to 2018-09-30 | 138,695,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2018-01-01 to 2018-09-30 | $2.51bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2018-01-01 to 2018-09-30 | $436.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2018-01-01 to 2018-09-30 | $195.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2018-01-01 to 2018-09-30 | $294.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-09-30 | $4.14bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-09-30 | $19.08bn | us-gaap:AssetsCurrent |
| Total assets | At period end2018-09-30 | $27.49bn | us-gaap:Assets |
| Current liabilities | At period end2018-09-30 | $11.32bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-09-30 | $16.90bn | us-gaap:Liabilities |
| Long-term debt | At period end2018-09-30 | $4.77bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2018-09-30 | $398.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2018-09-30 | $10.59bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2018-09-30 | 137,186,880 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000049071-18-000123. Last ingested by Listed: Nov 6, 2026, 14:15 ET. Listed shows no prices and gives no investment advice.